Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

A 73-year-old man's grey-white hair turned dark brown after eczema treatment.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The combination therapy was effective and well-tolerated, especially in young patients.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Infliximab may cause hair loss in Crohn's disease patients.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

A cat with severe skin issues improved with dexamethasone and cetirizine.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Dupilumab can cause lupus-like symptoms, so patients need careful monitoring.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.